Public healthfromIPWatchdog.com | Patents & Intellectual Property Law2 weeks agoForeign Price Controls: A Risk to U.S. Medical Innovation and Patient AccessPrice controls on medicines jeopardize innovation and patient access, benefiting foreign price setting over U.S. market principles.
US politicsfromwww.mediaite.com2 months agoTrump Embrace of Price Controls is U-Turn From Campaign When He Said They Don't Work' And Make Problems WorseTrump signed an executive order to cut prescription drug prices significantly, directing consumers to buy directly from manufacturers.
US politicsfromNew York Post2 months agoTrump says famous friend got 'fat shot' cheaper overseas - and drug executive copped to overchargingTrump reveals a friend was shocked by the price disparity of pharmaceuticals abroad compared to the U.S.
Alternative medicinefromPatently-O5 months agoGeneric Drugs, Skinny Labels, and Liability for Off Label (Infringing) UseHikma's petition seeks clarification on generic drug marketing liability regarding 'skinny labels' under patent law.
fromBusiness Insider10 months agoInsider Today: Austin's genius housing fix"Sen. Bernie Sanders pointed out during Wednesday's hearing that Ozempic costs an average of $969 monthly in the US, compared to $59 in Germany. Wegovy averages $1,349 a month in the US, while in Germany, it's only $140."Privacy professionals